Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
ADV7103
DRUG
5 trials
Sponsors
Advicenne Pharma
Conditions
Acidosis, Renal Tubular
Cystinuria
Distal Renal Tublular Acidosis
Distal Renal Tubular Acidosis
EFFECT OF ADV7103 ON GASTRIC PH
Phase 1
A Phase 1 Study, to Evaluate the Effect of ADV7103 on Gastric pH Under Fed and Fasting Conditions in Adult Healthy Participants.
Completed
NCT07446881
Advicenne Pharma
Distal Renal Tublular Acidosis, EFFECT OF ADV7103 ON GASTRIC PH
Start: 2025-02-25
End: 2025-03-15
Updated: 2026-03-10
Phase 2
Study Evaluating Patients With Cystinuria
Withdrawn
NCT04137978
Advicenne Pharma
Cystinuria
Start: 2024-05-01
End: 2025-08-31
Updated: 2024-03-12
Study Evaluating Patients With Cystinuria and Efficacy and Safety Exploratory Study in the Youngest Children
Withdrawn
NCT04147871
Advicenne Pharma
Cystinuria
Start: 2024-03-01
End: 2025-06-01
Updated: 2026-01-08
Phase 3
Study Evaluating Subjects With Distal Renal Tubular Acidosis
Terminated
NCT03644706
Advicenne Pharma
Distal Renal Tubular Acidosis
Start: 2021-09-20
End: 2023-12-20
Updated: 2026-06-03
Extension Study in Primary Distal Renal Tubular Acidosis
Withdrawn
NCT03831152
Advicenne Pharma
Acidosis, Renal Tubular
Start: 2023-12-20
End: 2025-03-01
Updated: 2026-02-09
Related Papers
Improvement in Metabolic Control in Patients with Distal Renal Tubular Acidosis (dRTA) After Switching from Standard of Care to ADV7103
Journal of the American Society of Nephrology
2021-10-01